0.77
-1.53%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Oriola Oyj
Its shares trade on Nasdaq Helsinki under the ticker ORIOLA.HE. It has been listed since 3 July 2006. In the fiscal year to 31 December 2025, it reported revenue of €1.91bn and a net loss of €27.2m. At that date it held total assets of €946.1m and shareholders' equity of €100.8m.
Oriola Corp. engages in the provision of pharmaceutical, and health and well-being products retail and wholesale. The company is headquartered in Espoo, Etela-Suomen. The company went IPO on 2006-07-03. The firm is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The firm's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The firm is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 3 Jul 2006
- Employees
- 2,730
- Website
- oriola.com ↗
Leadership
Pay as last reported
- Mr. Heikki WesterlundNon-Executive Independent Chairman of the Board€85,500
- Ms. Katarina GabrielsonPresident, Chief Executive Officer, Member of the Executive Management Team€485,965
- Mr. Harri PaerssinenNon-Executive Independent Vice Chairman of the Board€52,500
- Mr. Mats DanielssonChief Financial Officer, Member of the Executive Management Team
- Mr. Niklas LindholmChief People Officer, Member of the Executive Management Team
- Mr. Stig TornellExecutive Vice President - Sales, Member of the Executive Management Team
- Ms. Katja LundellExecutive Vice President - Advisory Services, Member of the Executive Management Team
- Ms. Satu NylenExecutive Vice President - Services and Products, Member of the Executive Management Team
- Mr. Petter SandstroemGeneral Counsel, Member of the Executive Management Team
- Mr. Mikael NurmiChief Digital Officer, Member of the Executive Management Team
- Mr. Tuomas TiilikainenChief Supply Chain Officer, Member of the Executive Management Team
- Dna. Petra AxdorffNon-Executive Independent Director€43,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 83
- Environment
- 82
- Social
- 96
- Governance
- 71
- Direct emissions (scope 1)
- 66 t
- Energy emissions (scope 2)
- 614 t
- Value chain emissions (scope 3)
- 745,668 t
- Women in the workforce
- 53.31906%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Well-established presence in the healthcare industry.
- Strong distribution network across multiple countries.
- Diverse portfolio of products and services.
- Robust financial performance and stability.
Weaknesses
- Limited market share compared to larger competitors.
- Dependence on key suppliers for certain products.
- Insufficient brand recognition in some markets.
- Relatively high production costs impacting profitability.
Opportunities
- Increasing demand for healthcare products and services globally.
- Emerging markets offer expansion opportunities.
- Growing e-commerce sector provides avenues for online sales.
- Strategic partnerships and acquisitions to enhance market position.
Threats
- Intense competition from both existing and new players.
- Shifting regulatory environment impacting operations.
- Economic uncertainties affecting consumer spending.
- Technological advancements disrupting traditional business models.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.